Indeed, since the prenatal co-treatment of AMH with a GnRH antagonist successfully prevents the appearance of all PCOS-like neuroendocrine traits in female PAMH offspring, the finding suggests a critical pathogenic role for excess GnRH in developmental programming of PCOS and its maintenance (107). Here, GNRH1 is linked to polycystic ovary syndrome.